Главная
Study mode:
on
1
Intro
2
Structure-Function and Ligand design for GPCRs
3
Core Computational Technologies
4
Design of bitopic ligands for μ-Opioid Receptor
5
Modulating functional pathways of μ-Opioid receptor by targeting conserved Na* site
6
Ongoing and Emerging Directions Rational Structure-Based Ligand Design
7
Outline
8
How to Discover New Leads for a Protein Target?
9
Major Breakthroughs for Structure-Based VLS
10
REAL Space: On Demand Virtual Libraries for Screening
11
Proposed acceleration approaches
12
Idea: Use chemical modularity of REAL libraries
13
Selection of Minimal Fragments: Binding pose matters
14
V-SYNTHES Computational Benchmarking (with Binding Score & Pose selection)
15
Analogs-by-Catalog optimization of #523 series
16
V-SYNTHES 2.1-next level of scale and automation
17
V-SYNTHES collaborative applications to diverse targets
18
Enamine Libraries: from HTS to V-SYNTHES
19
Custom combinatorial libraries based on SuFEx "click" reaction
20
Novel Angiotensin AT2 antagonists for neuropathic pair From discovery to a (pre)clinical candidate
Description:
Explore a presentation from MolSoft's UGM 2023 by Dr. Vsevolod "Seva" Katritch of USC, focusing on computer-driven discovery of GPCR ligands with new chemotypes and functional selectivity. Delve into structure-function relationships and ligand design for GPCRs, core computational technologies, and the design of bitopic ligands for μ-Opioid Receptor. Learn about modulating functional pathways of μ-Opioid receptor by targeting conserved Na* site and discover ongoing and emerging directions in rational structure-based ligand design. Examine major breakthroughs in structure-based virtual ligand screening, including the use of REAL Space for on-demand virtual libraries. Understand proposed acceleration approaches, such as utilizing chemical modularity of REAL libraries and the importance of binding pose in selecting minimal fragments. Gain insights into V-SYNTHES computational benchmarking, analogs-by-catalog optimization, and collaborative applications to diverse targets. Explore Enamine Libraries' evolution from HTS to V-SYNTHES, custom combinatorial libraries based on SuFEx "click" reaction, and the development of novel Angiotensin AT2 antagonists for neuropathic pain, from discovery to (pre)clinical candidate stage. Read more

Computer-Driven Discovery of GPCR Ligands with New Chemotypes and Functional Selectivity

MolSoft Molecules in Silico
Add to list
0:00 / 0:00